Prognostic's Factors of Head and Neck Paragangliomas Evolution

Launched by HOSPICES CIVILS DE LYON · Jan 31, 2022

Keywords

ClinConnect Summary

This clinical trial is studying cervical paragangliomas, which are rare tumors found in the neck that can sometimes be linked to genetic factors. The trial aims to understand how these tumors progress over time and how they can be managed effectively. Current treatment options vary, with surgery often being the standard approach, but it can come with significant risks and complications. The researchers want to gather more information to help determine the best ways to treat and monitor patients with these tumors.

To participate in this study, individuals must be at least 18 years old and have a confirmed diagnosis of one or more cervical paragangliomas without having received specific treatment yet. Participants will be closely monitored over time to learn more about how these tumors behave and what treatment options may be most effective. This study aims to provide clearer guidelines for managing cervical paragangliomas and to enhance the understanding of these conditions for better patient care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Man or woman aged 18 or over
• • Patient with a confirmed diagnosis of one or multiple cervical paragangliomas regardless of genetic predisposition without specific therapy
• • Patient informed of the study details and who didn't opposed to participate in this research
• Exclusion Criteria:
• • Patient already treated without initial clinical and radiologic assessment standardized
• • Patient already treated with surgery, radiotherapy or systemic therapy for another paraganglioma
• • Patient with evolutive disease and life expectancy less than 2 years
• • Patient placed under legal protection
• • Patient participating in another interventional clinical study that may interfere with the results of this study